Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy

Oncogene

Volumn 22, Issue 23, 2003, Pages 3539-3547

  McKay, Tristan R ^a   Bell, Stephen ^a   Tenev, Tencho ^a   Stoll, Viola ^a   Lopes, Rita ^a   Lemoine, Nicholas R ^a   McNeish, Iain A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Caspase; Gene therapy; Ovarian carcinoma; Survivin

Indexed keywords

ADENOVIRUS VECTOR; CASPASE 3; CASPASE 9; PROCASPASE 3; SURVIVIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CELL CYCLE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; METAPHASE; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; UPREGULATION; VIRAL GENE THERAPY; VIRUS GENE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CARCINOMA; CASPASE 3; CASPASE 9; CASPASES; CELL CYCLE; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME PRECURSORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, DOMINANT; HUMANS; MICE; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION; NEOPLASM PROTEINS; NOCODAZOLE; OVARIAN NEOPLASMS; SURVIVAL RATE; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA; FALLOPIA; MURINAE;

EID: 0037784054     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206417     Document Type: Article

References (46)

1. Adams RR, Carmena M and Earnshaw WC. (2001). Trends Cell Biol., 11, 49-54.
2. Ambrosini G, Adida C, Sirugo G and Altieri DC. (1998). J. Biol. Chem., 273, 11177-111782.
3. Asanuma K, Moriai R, Yajima T, Yagihashi A, Yamada M, Kobayashi D and Watanabe N. (2000). Jpn. J. Cancer Res., 91, 1204-1209.
4. Banks DP, Plescia J, Altieri DC, Chen J, Rosenberg SH, Zhang H and Ng SC. (2000). Blood, 96, 4002-4003.
5. Blanc-Brude OP, Yu J, Simosa H, Conte MS, Sessa WC and Altieri DC. (2002). Nat. Med., 8, 987-994.
6. Bratton SB, Walker G, Srinivasula SM, Sun XM, Butterworth M, Alnemri ES and Cohen GM. (2001). EMBO J., 20, 998-1009.
7. Chai J, Du C, Wu JW, Kyin S, Wang X and Shi Y. (2000). Nature, 406, 855-862.
8. Chen J, Wu W, Tahir SK, Kroeger PE, Rosenberg SH, Cowsert LM, Bennett F, Krajewski S, Krajewska M, Welsh K, Reed JC and Ng SC. (2000). Neoplasia, 2, 235-241.
9. Conway EM, Pollefeyt S, Cornelissen J, DeBaere I, Steiner-Mosonyi M, Ong K, Baens M, Collen D and Schuh AC. (2000). Blood, 95, 1435-1442.
10. Deveraux QL, Takahashi R, Salvesen GS and Reed JC. (1997). Nature, 388, 300-304.
11. Dong Z, Nishiyama J, Yi XL, Venkatachalam MA, Denton M, Gu SM, Li SL and Qiang M. (2002). Biochem. J., 364, 413-421.
12. Du C, Fang M, Li Y, Li L and Wang X. (2000). Cell, 102, 33-42.
13. Grossman D, Kim PJ, Schechner JS and Altieri DC. (2001). Proc. Natl. Acad. Sci. USA, 98, 635-640.
14. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B. (1998). Proc. Natl. Acad. Sci. USA, 95, 2509-2514.
15. Ikeguchi M, Nakamura S and Kaibara N. (2002). Oncol. Rep., 9, 1121-1126.
16. Kovarik A, Peat N, Wilson D, Gendler S and Taylor-Papadimitriou J. (1993). J. Biol. Chem., 268, 99179926.
17. Lavoie JN, Nguyen M, Marcellus RC, Branton PE and Shore GC. (1998). J. Cell Biol., 140, 637-645.
18. Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC and Altieri DC. (1999). Nat. Cell Biol., 1, 461-466.
19. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC and Altieri DC. (1998). Nature, 396, 580-584.
20. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A and Korneluk RG. (1996). Nature, 379, 349-353.
21. Livne A, Shtrichman R and Kleinberger T. (2001). J. Virol., 75, 789-798.
22. McNeish IA, Tenev T, Bell S, Marani M, Vassaux G and Lemoine N. (2001). Cancer Gene Ther., 8, 308-319.
23. Mesri M, Wall NR, Li J, Kim RW and Altieri DC. (2001). J. Clin. Invest., 108, 981-990.
24. Nicholson D. (1999). Cell Death Differ., 6, 1028-1042.
25. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio PC and Altieri DC. (2000). Proc. Natl. Acad. Sci. USA, 97, 13103-13107.
26. Sarela AI, Macadam RC, Farmery SM, Markham AF and Guillou PJ. (2000). Gut, 46, 645-650.
27. Shariat SF, Desai S, Song W, Khan T, Zhao J, Nguyen C, Foster BA, Greenberg N, Spencer DM and Slawin KM. (2001). Cancer Res., 61, 2562-2571.
28. Shin S, Sung B J, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK and Oh BH, (2001). Biochemistry, 40, 1117-1123.
29. Shinoura N, Muramatsu Y, Yoshida Y, Asai A, Kirino T and Hamada H. (2000). Exp. Cell Res., 256, 423-433.
30. Silke J, Ekert PG, Day CL, Hawkins CJ, Baca M, Chew J, Pakusch M, Verhagen AM and Vaux DL. (2001). EMBO J., 20, 3114-3123.
31. Silke J and Vaux DL. (2001). J. Cell Sci., 114, 1821-1827.
32. Skoufias DA, Mollinari C, Lacroix FB and Margolis RL. (2000). J. Cell Biol., 151, 1575-1582.
33. Speliotes EK, Uren A, Vaux D and Horvitz HR. (2000). Mol. Cell, 6, 211-223.
34. Suzuki A, Hayashida M, Ito T, Kawano H, Nakano T, Miura M, Akahane K and Shiraki K. (2000). Oncogene, 19, 3225-3234.
35. Takahashi R, Deveraux Q, Tamm I., Welsh K, Assa-Munt N, Salvesen GS and Reed JC. (1998). J. Biol. Chem., 273, 7787-7790.
36. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T and Reed JC. (1998). Cancer Res., 58, 5315-5320.
37. Tenev T, Marani M, McNeish I and Lemoine NR. (2001). Cell Death Differ., 8, 256-264.
38. Uren AG, Wong L, Pakusch M, Fowler K J, Burrows FJ, Vaux DL and Choo KH. (2000). Curr. Biol., 10, 1319-1328.
39. Vasquez R J, Howell B, Yvon AM, Wadsworth P and Cassimeris L. (1997). Mol. Biol. Cell, 8, 973-985.
40. Verdecia MA, Huang H, Dutil E, Kaiser DA, Hunter T and Noel JP. (2000). Nat. Struct. Biol., 7, 602-608.
41. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL. (2000). Cell, 102, 43-53.
42. Wall NR, O'Connor DS, Plescia J, Pommier Y and Altieri DC. (2003). Cancer Res., 63, 230-235.
43. Yamabe K, Shimizu S, Ito T, Yoshioka Y, Nomura M, Narita M, Saito I, Kanegae Y and Matsuda H. (1999). Gene Therapy., 6, 1952-1959.
44. Yoshida H, Ishiko O, Sumi T, Matsumoto Y and Ogita S. (2001). Int. J. Oncol., 19, 537-542.
45. Zhao J, Tenev T, Martins LM, Downward J and Lemoine NR. (2000). J. Cell Sci., 113, 4363-4371.
46. Zou H, Li Y, Liu X and Wang X. (1999). J. Biol. Chem., 274, 11549-11556.